Combitaz 250mg/31.25mg Injection
Marketer
Lupin Ltd
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Combitaz 250mg/31.25mg Injection
Combating bacterial infections, the dual-action Combitaz 250mg/31.25mg Injection requires professional administration. This medication combats microbial proliferation, preventing infection spread. Complete the prescribed course, even with symptom improvement; premature cessation may reduce efficacy. Regularly scheduled doses are crucial. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) require emergency care. Inform your physician of all current medications, including those for pre-existing conditions. Consult your doctor before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration promote recovery. Monitoring may involve diagnostic tests to assess treatment effectiveness.
Primary Ingredients of Combitaz 250mg/31.25mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Combitaz 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Combitaz 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Combitaz 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Combitaz 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Combitaz 250mg/31.25mg Injection works:
Combitaz Injection (250mg/31.25mg) unites Ceftazidime, a crucial antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Tazobactum's role is to counteract bacterial resistance, thereby optimizing Ceftazidime's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Combitaz 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Combitaz 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Combitaz 250mg/31.25mg is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Administering Combitaz 250mg/31.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Caution is advised when administering Combitaz 250mg/31.25mg Injection to individuals with impaired renal function. Dosage modification for Combitaz 250mg/31.25mg Injection may be necessary. Physician consultation is recommended.
LiverCAUTION
Administering Combitaz 250mg/31.25mg Injection to individuals suffering from severe hepatic impairment requires careful consideration. Dosage modification of Combitaz 250mg/31.25mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Combitaz 250mg/31.25mg Injection :
Omitting a scheduled dose of Combitaz 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Combitaz 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infective Agents Inhibitors |
3,018 People bought this recently